Cardio-oncology care in German hospitals: a multicentre inpatient survey of practices, perceptions and guideline gaps.

Pre-chemotherapy risk stratification was reported by 85.4% of oncologists and gynaecologists, yet cardiologists were involved in only 28-35%, with heterogeneous risk parameters across specialties.

In high-risk patients (anthracyclines plus pre-existing heart failure), gynaecologists monitored significantly less than oncologists at every time point, with 12-month surveillance at 5.3% versus 54.2% (p = 0.001); acute cardiac events were the predominant trigger (36.8%), reflecting reactive rather than proactive practice.